Preview

Rational Pharmacotherapy in Cardiology

Advanced search

ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES

https://doi.org/10.20996/1819-6446-2005-1-1-4-8

Full Text:

Abstract

Aim. To prove the advantage of the long-term controlled antihypertensive therapy compared with the real usual standard therapy in patients with mild to moderate arterial hypertension.

Material and methods. It was multicenter, randomized, prospective parallel-group study in patients with mild to moderate hypertension. One part of patients (treatment group) received the strongly regulated stepped antihypertensive therapy based on ACE-inhibitor spirapril, the second one (con￾trol group) continued their usual standard therapy prescribed by doctors of polyclinics or other patient care institutions. The study lasted one year.

Results. 1742 patients were enrolled in the study, 854 patients were included in the treatment group and 888 – in the control group. 220 patients dropped out of the study by different reasons, and 1552 patients finished the study. There were 651 (37,6%) men and 1081 (62,4%) women. It was substantial decrease in blood pressure in both group, but distinctions between systolic and diastolic blood pressure in the treatment and control group during the study were significant.

The target levels of blood pressure (systolic < 140 mm Hg and diastolic < 90 mm Hg) were registered substantially more frequent in the patients of treatment group than in control group (69,4% и 39,3% after three months and 83,6% и 66,9% after 12 months of the treatment correspondingly).

Conclusion. Controlled stepped antihypertensive therapy resulted into more significant decrease in systolic and diastolic blood pressure and more frequent achievement of target levels of blood pressure in comparison with control group. It supposes better prognosis of patients.

About the Authors

S. A. Shalnova
State Reserch Center for Preventive Medicine, Ministry of Health and Social Development of Russia, Moscow
Russian Federation


S. Y. Martsevich
State Reserch Center for Preventive Medicine, Ministry of Health and Social Development of Russia, Moscow
Russian Federation


A. D. Deev
State Reserch Center for Preventive Medicine, Ministry of Health and Social Development of Russia, Moscow
Russian Federation


N. P. Kutishenko
State Reserch Center for Preventive Medicine, Ministry of Health and Social Development of Russia, Moscow
Russian Federation


P. G. Oganov
State Reserch Center for Preventive Medicine, Ministry of Health and Social Development of Russia, Moscow
Russian Federation


A. N. Britov

Russian Federation


E. G. Volkova

Russian Federation


K. I. Ivanov

Russian Federation


A. M. Kalinina

Russian Federation


L. I. Katelnitskaya

Russian Federation


G. D. Kobalava

Russian Federation


E. V. Kokurina

Russian Federation


A. O. Conradi

Russian Federation


S. K. Kukushkin

Russian Federation


Yu. M. Lopatin

Russian Federation


N. I. Maksimov

Russian Federation


V. Y. Mareev

Russian Federation


I. S. Petelin

Russian Federation


D. V. Nebieridze

Russian Federation


G. I. Nechayev

Russian Federation


L. A. Sokolova

Russian Federation


A. V. Suslikov

Russian Federation


I. G. Fomina

Russian Federation


A. V. Shabalin

Russian Federation


V. A. Shulman

Russian Federation


V. V. Yakusevich

Russian Federation


S. S. Jakushin

Russian Federation


References

1. Шальнова С.А., Деев А.Д., Вихирева О.В. и др. Распространенность артериальной гипертонии в России. Информированность, лечение, контроль. Профилактика заболеваний и укрепление здоровья 2001; 2: 3-7.

2. Stokes J., Kannel W., Wolf P. et al. Blood pressure as a risk factor fjr cardiovascular disease. The Framingham Study – 30 years of follow￾up. Hypertension 1989; 13 (Suppl. I): 13-18.

3. Waeber B. Treatment strategy to control blood pressure optimally in hypertensive patients. Blood Pressure 2001; 10: 62-73.

4. Chobanian A.V., Bakris G.L., Black H.R. et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003;289:2560- 2572.

5. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J. Hypertension 2003; 21: 1011-1053.

6. Шальнова С.А., Марцевич С.Ю., Деев А.Д. и др. Сравнительное изучение эффективности спираприла (квадроприл) и амлодипина. Результаты рандомизированного исследования у больных мягкой и умеренной артериальной гипертонией . Тер.архив 2000; 10:86-89.

7. Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomised trials. Lancet 2003; 362:1527-1535.


For citation:


Shalnova S.A., Martsevich S.Y., Deev A.D., Kutishenko N.P., Oganov P.G., Britov A.N., Volkova E.G., Ivanov K.I., Kalinina A.M., Katelnitskaya L.I., Kobalava G.D., Kokurina E.V., Conradi A.O., Kukushkin S.K., Lopatin Yu.M., Maksimov N.I., Mareev V.Y., Petelin I.S., Nebieridze D.V., Nechayev G.I., Sokolova L.A., Suslikov A.V., Fomina I.G., Shabalin A.V., Shulman V.A., Yakusevich V.V., Jakushin S.S. ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES. Rational Pharmacotherapy in Cardiology. 2005;1(1):4-8. (In Russ.) https://doi.org/10.20996/1819-6446-2005-1-1-4-8

Views: 425


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)